CIK: 0001646343
申告総資産額
$1.2億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XBI | Ss Spdr S&p Biotech ETF | ETF-テック型 | 31.29% | — | +33.33% | |
| 2 | ✓ | 株式-その他 | 6.27% | -1.96% | — | ||
| 3 | ✓ | Shire PLC | 株式-その他 | 4.63% | — | +132.53% | |
| 4 | BMRN | Biomarin Pharmaceutical INC | 株式-ヘルスケア | 4.40% | -0.89% | EXIT | |
| 5 | ✓ | Mylan N V | 株式-その他 | 3.67% | +1.63% | NEW | |
| 6 | MRK | Merck & Co. INC. | 株式-ヘルスケア | 3.59% | — | — | |
| 7 | BMY | Bristol-myers Squibb Co | 株式-ヘルスケア | 3.34% | — | — | |
| 8 | AZNN | Astrazeneca Plc-spons Adr | 株式-その他 | 2.98% | — | — | |
| 9 | ✓ | Ablynx NV - Adr | 株式-その他 | 2.94% | — | — | |
| 10 | CLVSEUR | Clovis Oncology INC | 株式-その他 | 2.92% | — | +6.15% | |
| 11 | INSM | Insmed INC | 株式-ヘルスケア | 2.87% | +0.01% | +246.47% | |
| 12 | DOVA | Dova Pharmaceuticals INC | 株式-その他 | 2.41% | — | +3.40% | |
| 13 | GBTUSD | Global Blood Therapeutics In | 株式-その他 | 2.26% | +0.64% | +15.34% | |
| 14 | ✓ | Flexion Therapeutics INC | 株式-その他 | 2.15% | — | +72.05% | |
| 15 | SGMOQ | Sangamo Therapeutics INC | 株式-その他 | 2.14% | — | -9.28% | |
| 16 | ALNY | Alnylam Pharmaceuticals INC | 株式-ヘルスケア | 2.02% | — | +8.17% | |
| 17 | FGENEUR | Fibrogen INC | 株式-その他 | 1.76% | — | -7.59% | |
| 18 | SG7 | Sage Therapeutics INC | 株式-その他 | 1.70% | -1.20% | EXIT | |
| 19 | ✓ | Sucampo Pharmaceuticals INC | 株式-その他 | 1.69% | — | — | |
| 20 | ALXN | Alexion Pharmaceuticals INC | 株式-その他 | 1.60% | — | +16.14% | |
| 21 | GLYCEUR | Glycomimetics INC | 株式-その他 | 1.49% | — | +49.54% | |
| 22 | MRNSUSD | Marinus Pharmaceuticals INC | 株式-その他 | 1.39% | — | +54.22% | |
| 23 | KURA | Kura Oncology INC | 株式-その他 | 1.26% | — | +72.35% | |
| 24 | IMMU | Immunomedics INC | 株式-その他 | 1.21% | -1.74% | -48.93% | |
| 25 | ATRAGBX | Atara Biotherapeutics INC | 株式-その他 | 0.96% | — | — | |
| 26 | CBAYUSD | Cymabay Therapeutics INC | 株式-その他 | 0.91% | -3.39% | EXIT | |
| 27 | SPPIUSD | Spectrum Pharmaceuticals INC | 株式-その他 | 0.91% | — | — | |
| 28 | ✓ | Gyre Therapeutics INC Com | 株式-その他 | 0.78% | — | — | |
| 29 | ✓ | Avadel Pharmaceuticals PLC | 株式-その他 | 0.76% | — | — | |
| 30 | T8S | Tesaro INC | 株式-その他 | 0.76% | — | — | |
| 31 | CTMX | Cytomx Therapeutics INC | 株式-その他 | 0.70% | — | — | |
| 32 | OTICEUR | Otonomy INC | 株式-その他 | 0.62% | — | — | |
| 33 | TXMDEUR | Therapeuticsmd INC | 株式-その他 | 0.59% | — | — | |
| 34 | ANIP | Ani Pharmaceuticals INC | 株式-その他 | 0.50% | — | — | |
| 35 | 4XC1 | Kalvista Pharmaceuticals INC | 株式-その他 | 0.33% | — | — | |
| 36 | ZFGNUSD | Zafgen INC | 株式-その他 | 0.15% | — | — | |
| 37 | TGTX | Tg Therapeutics INC | 株式-ヘルスケア | 0.05% | — | — | |
| 38 | VTGNUSD | Vistagen Therapeutics INC | 株式-その他 | 0.03% | — | — |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | ✓ | Shire PLC | +1.9% | +132.53% | 増加 |
| 2 | INSM | Insmed INC | +1.7% | +246.47% | 増加 |
| 3 | BMRN | Biomarin Pharmaceutical INC | +1.5% | +123.63% | 増加 |
| 4 | CBAYUSD | Cymabay Therapeutics INC | +0.9% | +3477.12% | 増加 |
| 5 | MRNSUSD | Marinus Pharmaceuticals INC | +0.5% | +54.22% | 増加 |
| 6 | ✓ | Flexion Therapeutics INC | +0.5% | +72.05% | 増加 |
| 7 | GLYCEUR | Glycomimetics INC | +0.3% | +49.54% | 増加 |
| 8 | KURA | Kura Oncology INC | +0.3% | +72.35% | 増加 |
| 9 | GBTUSD | Global Blood Therapeutics In | +0.1% | +15.34% | 増加 |
| 10 | DOVA | Dova Pharmaceuticals INC | -0.3% | +3.40% | 増加 |
| 11 | ALNY | Alnylam Pharmaceuticals INC | -0.4% | +8.17% | 増加 |
| 12 | T8S | Tesaro INC | -0.9% | — | 変化なし |
| 13 | FGENEUR | Fibrogen INC | -1.3% | -7.59% | 減少 |
| 14 | IMMU | Immunomedics INC | -1.6% | -48.93% | 減少 |
| 15 | CLVSEUR | Clovis Oncology INC | -1.7% | +6.15% | 増加 |
| 16 | XBI | Ss Spdr S&p Biotech ETF | -2.1% | +33.33% | 増加 |
| 17 | ✓ | — | NEW | 新規購入 | |
| 18 | SGENEUR | Seagen INC | — | EXIT | 全売却 |
| 19 | ✓ | Mylan N V | — | NEW | 新規購入 |
| 20 | MRK | Merck & Co. INC. | — | NEW | 新規購入 |
| 21 | BMY | Bristol-myers Squibb Co | — | NEW | 新規購入 |
| 22 | TEVA | Teva Pharmaceutical-sp Adr | — | EXIT | 全売却 |
| 23 | AZNN | Astrazeneca Plc-spons Adr | — | NEW | 新規購入 |
| 24 | ✓ | Ablynx NV - Adr | — | NEW | 新規購入 |
| 25 | GSK | GSK plc ADRhedged | — | EXIT | 全売却 |
| 26 | ACRS | Aclaris Therapeutics INC | — | EXIT | 全売却 |
| 27 | AKAOQ | Achaogen INC | — | EXIT | 全売却 |
| 28 | SG7 | Sage Therapeutics INC | — | NEW | 新規購入 |
| 29 | ✓ | Sucampo Pharmaceuticals INC | — | NEW | 新規購入 |
| 30 | IPXLEUR | Impax Laboratories INC | — | EXIT | 全売却 |
| 31 | ARRYEUR | Array Biopharma INC | — | EXIT | 全売却 |
| 32 | PRTKEUR | Paratek Pharmaceuticals INC | — | EXIT | 全売却 |
| 33 | SUPN | Supernus Pharmaceuticals INC | — | EXIT | 全売却 |
| 34 | ATRAGBX | Atara Biotherapeutics INC | — | NEW | 新規購入 |
| 35 | ABEO1EUR | Abeona Therapeutics INC | — | EXIT | 全売却 |
| 36 | SPPIUSD | Spectrum Pharmaceuticals INC | — | NEW | 新規購入 |
| 37 | ✓ | Gyre Therapeutics INC Com | — | NEW | 新規購入 |
| 38 | ✓ | Avadel Pharmaceuticals PLC | — | NEW | 新規購入 |
| 39 | NERVGBP | Minerva Neurosciences INC | — | EXIT | 全売却 |
| 40 | CTMX | Cytomx Therapeutics INC | — | NEW | 新規購入 |
| 41 | ✓ | Ignyta INC | — | EXIT | 全売却 |
| 42 | OTICEUR | Otonomy INC | — | NEW | 新規購入 |
| 43 | TXMDEUR | Therapeuticsmd INC | — | NEW | 新規購入 |
| 44 | ANIP | Ani Pharmaceuticals INC | — | NEW | 新規購入 |
| 45 | ✓ | Intec Pharma LTD Jerusalem | — | EXIT | 全売却 |
| 46 | 4XC1 | Kalvista Pharmaceuticals INC | — | NEW | 新規購入 |
| 47 | MDGL | Madrigal Pharmaceuticals INC | — | EXIT | 全売却 |
| 48 | ✓ | Steadymed LTD | — | EXIT | 全売却 |
| 49 | ZFGNUSD | Zafgen INC | — | NEW | 新規購入 |
| 50 | ZSANGBP | Zosano Pharma CORP | — | EXIT | 全売却 |